|
|
||||||||



*
Department of Pathology University of Michigan Medical School, Ann Arbor, MI 48109; and
Department of Immunology, Genentech, South San Francisco, CA 94080
In humans with sepsis, the onset of multiorgan failure (MOF), especially involving liver, lungs, and kidneys, is a well known complication that is associated with a high mortality rate. Our previous studies with the cecal ligation/puncture (CLP) model of sepsis in rats have revealed a C5a-induced defect in the respiratory burst of neutrophils. In the current CLP studies, MOF occurred during the first 48 h with development of liver dysfunction and pulmonary dysfunction (falling arterial partial pressure of O2, rising partial pressure of CO2). In this model an early respiratory alkalosis developed, followed by a metabolic acidosis with increased levels of blood lactate. During these events, blood neutrophils lost their chemotactic responsiveness both to C5a and to the bacterial chemotaxin, fMLP. Neutrophil dysfunction was associated with virtually complete loss in binding of C5a, but binding of fMLP remained normal. If CLP animals were treated with anti-C5a, indicators of MOF and lactate acidosis were greatly attenuated. Under the same conditions, C5a binding to blood neutrophils remained intact; in tandem, in vitro chemotactic responses to C5a and fMLP were retained. These data suggest that, in the CLP model of sepsis, treatment with anti-C5a prevents development of MOF and the accompanying onset of blood neutrophil dysfunction. This may explain the protective effects of anti-C5a in the CLP model of sepsis.
This article has been cited by other articles:
![]() |
L. Sun, R.-F. Guo, H. Gao, J. V. Sarma, F. S. Zetoune, and P. A. Ward Attenuation of IgG immune complex-induced acute lung injury by silencing C5aR in lung epithelial cells FASEB J, November 1, 2009; 23(11): 3808 - 3818. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Miki, A. Kumar, R. Yang, M. E. Killeen, and R. L. Delude Extracellular activation of arginase-1 decreases enterocyte inducible nitric oxide synthase activity during systemic inflammation Am J Physiol Gastrointest Liver Physiol, October 1, 2009; 297(4): G840 - G848. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. N. Pushparaj, H. K. Tay, C.-C. Wang, W. Hong, and A. J. Melendez VAMP8 Is Essential in Anaphylatoxin-Induced Degranulation, TNF-{alpha} Secretion, Peritonitis, and Systemic Inflammation J. Immunol., July 15, 2009; 183(2): 1413 - 1418. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Conway Morris, K. Kefala, T. S. Wilkinson, K. Dhaliwal, L. Farrell, T. Walsh, S. J. Mackenzie, H. Reid, D. J. Davidson, C. Haslett, et al. C5a Mediates Peripheral Blood Neutrophil Dysfunction in Critically Ill Patients Am. J. Respir. Crit. Care Med., July 1, 2009; 180(1): 19 - 28. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Goring, Y. Huang, C. Mowat, C. Leger, T.-H. Lim, R. Zaheer, D. Mok, L. A. Tibbles, D. Zygun, and B. W. Winston Mechanisms of human complement factor B induction in sepsis and inhibition by activated protein C Am J Physiol Cell Physiol, May 1, 2009; 296(5): C1140 - C1150. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Flierl, D. Rittirsch, B. A. Nadeau, D. E. Day, F. S. Zetoune, J. V. Sarma, M. S. Huber-Lang, and P. A. Ward Functions of the complement components C3 and C5 during sepsis FASEB J, October 1, 2008; 22(10): 3483 - 3490. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. N. Patel, J. Berghout, F. E. Lovegrove, K. Ayi, A. Conroy, L. Serghides, G. Min-oo, D. C. Gowda, J. V. Sarma, D. Rittirsch, et al. C5 deficiency and C5a or C5aR blockade protects against cerebral malaria J. Exp. Med., May 12, 2008; 205(5): 1133 - 1143. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Lattin, D. A. Zidar, K. Schroder, S. Kellie, D. A. Hume, and M. J. Sweet G-protein-coupled receptor expression, function, and signaling in macrophages J. Leukoc. Biol., July 1, 2007; 82(1): 16 - 32. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Rittirsch, L. M. Hoesel, and P. A. Ward The disconnect between animal models of sepsis and human sepsis J. Leukoc. Biol., January 1, 2007; 81(1): 137 - 143. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Ritis, M. Doumas, D. Mastellos, A. Micheli, S. Giaglis, P. Magotti, S. Rafail, G. Kartalis, P. Sideras, and J. D. Lambris A Novel C5a Receptor-Tissue Factor Cross-Talk in Neutrophils Links Innate Immunity to Coagulation Pathways J. Immunol., October 1, 2006; 177(7): 4794 - 4802. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. E. Wesche, J. L. Lomas-Neira, M. Perl, C.-S. Chung, and A. Ayala Leukocyte apoptosis and its significance in sepsis and shock J. Leukoc. Biol., August 1, 2005; 78(2): 325 - 337. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. P. Vlasenko and A. J. Melendez A Critical Role for Sphingosine Kinase in Anaphylatoxin-Induced Neutropenia, Peritonitis, and Cytokine Production in Vivo J. Immunol., May 15, 2005; 174(10): 6456 - 6461. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Huber-Lang, J. V. Sarma, D. Rittirsch, H. Schreiber, M. Weiss, M. Flierl, E. Younkin, M. Schneider, H. Suger-Wiedeck, F. Gebhard, et al. Changes in the Novel Orphan, C5a Receptor (C5L2), during Experimental Sepsis and Sepsis in Humans J. Immunol., January 15, 2005; 174(2): 1104 - 1110. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. C. Riedemann, R.-F. Guo, and P. A. Ward A key role of C5a/C5aR activation for the development of sepsis J. Leukoc. Biol., December 1, 2003; 74(6): 966 - 970. [Abstract] [Full Text] |
||||
![]() |
I. Farkas, M. Takahashi, A. Fukuda, N. Yamamoto, H. Akatsu, L. Baranyi, H. Tateyama, T. Yamamoto, N. Okada, and H. Okada Complement C5a Receptor-Mediated Signaling May Be Involved in Neurodegeneration in Alzheimer's Disease J. Immunol., June 1, 2003; 170(11): 5764 - 5771. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. C. Riedemann, T. A. Neff, R.-F. Guo, K. D. Bernacki, I. J. Laudes, J. V. Sarma, J. D. Lambris, and P. A. Ward Protective Effects of IL-6 Blockade in Sepsis Are Linked to Reduced C5a Receptor Expression J. Immunol., January 1, 2003; 170(1): 503 - 507. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. HUBER-LANG, N. C. RIEDEMAN, J. V. SARMA, E. M. YOUNKIN, S. R. McGUIRE, I. J. LAUDES, K. T. LU, R.-F. GUO, T. A. NEFF, V. A. PADGAONKAR, et al. Protection of innate immunity by C5aR antagonist in septic mice FASEB J, October 1, 2002; 16(12): 1567 - 1574. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Huber-Lang, E. M. Younkin, J. V. Sarma, S. R. McGuire, K. T. Lu, R. F. Guo, V. A. Padgaonkar, J. T. Curnutte, R. Erickson, and P. A. Ward Complement-Induced Impairment of Innate Immunity During Sepsis J. Immunol., September 15, 2002; 169(6): 3223 - 3231. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. E. Mollnes, O.-L. Brekke, M. Fung, H. Fure, D. Christiansen, G. Bergseth, V. Videm, K. T. Lappegard, J. Kohl, and J. D. Lambris Essential role of the C5a receptor in E coli-induced oxidative burst and phagocytosis revealed by a novel lepirudin-based human whole blood model of inflammation Blood, August 13, 2002; 100(5): 1869 - 1877. [Abstract] [Full Text] [PDF] |
||||
![]() |
R.-F. Guo, N. C. Riedemann, I. J. Laudes, V. J. Sarma, R. G. Kunkel, K. A. Dilley, J. D. Paulauskis, and P. A. Ward Altered Neutrophil Trafficking During Sepsis J. Immunol., July 1, 2002; 169(1): 307 - 314. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. J. Laudes, J. C. Chu, S. Sikranth, M. Huber-Lang, R.-F. Guo, N. Riedemann, J. V. Sarma, A. H. Schmaier, and P. A. Ward Anti-C5a Ameliorates Coagulation/Fibrinolytic Protein Changes in a Rat Model of Sepsis Am. J. Pathol., May 1, 2002; 160(5): 1867 - 1875. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. C. Riedemann, R.-F. Guo, V. J. Sarma, I. J. Laudes, M. Huber-Lang, R. L. Warner, E. A. Albrecht, C. L. Speyer, and P. A. Ward Expression and Function of the C5a Receptor in Rat Alveolar Epithelial Cells J. Immunol., February 15, 2002; 168(4): 1919 - 1925. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-K. Yum, J. Arcaroli, J. Kupfner, R. Shenkar, J. M. Penninger, T. Sasaki, K.-Y. Yang, J. S. Park, and E. Abraham Involvement of Phosphoinositide 3-Kinases in Neutrophil Activation and the Development of Acute Lung Injury J. Immunol., December 1, 2001; 167(11): 6601 - 6608. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. S. Olson, K. Singbartl, and K. Ley L-selectin is required for fMLP- but not C5a-induced margination of neutrophils in pulmonary circulation Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2002; 282(4): R1245 - R1252. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |